SABA, PIERLUIGI
 Distribuzione geografica
Continente #
EU - Europa 56.182
NA - Nord America 3.257
AS - Asia 498
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
Totale 59.955
Nazione #
IT - Italia 55.244
US - Stati Uniti d'America 3.250
CN - Cina 347
SE - Svezia 319
UA - Ucraina 295
DE - Germania 112
SG - Singapore 89
GB - Regno Unito 80
FI - Finlandia 68
FR - Francia 19
KR - Corea 19
IN - India 18
RU - Federazione Russa 12
VN - Vietnam 12
BE - Belgio 9
BR - Brasile 9
CA - Canada 7
PL - Polonia 7
NL - Olanda 6
EU - Europa 5
CZ - Repubblica Ceca 4
AT - Austria 3
HK - Hong Kong 3
JP - Giappone 3
PT - Portogallo 3
CL - Cile 2
IR - Iran 2
TR - Turchia 2
IE - Irlanda 1
IQ - Iraq 1
MA - Marocco 1
MU - Mauritius 1
TH - Thailandia 1
TW - Taiwan 1
Totale 59.955
Città #
Cagliari 54.234
Uta 819
Woodbridge 383
Fairfield 381
Chandler 336
Houston 267
Ashburn 250
Nyköping 214
Ann Arbor 200
Jacksonville 152
Seattle 150
Boardman 149
Dearborn 146
Wilmington 135
Cambridge 128
Shanghai 64
Santa Clara 52
Nanjing 51
Singapore 44
Boston 41
Beijing 36
San Diego 27
Helsinki 25
Santa Maria Coghínas 20
Seoul 18
Washington 18
Shenyang 17
Hebei 16
Los Angeles 15
Nanchang 15
Jinan 14
Milan 14
Munich 14
Guangzhou 13
Dong Ket 12
Sassari 12
New York 11
Norwalk 11
Changsha 10
San Mateo 10
Falls Church 9
London 9
Redwood City 9
Verona 9
Brussels 8
Auburn Hills 7
Kunming 7
Leawood 7
Pune 7
Tianjin 7
Hefei 6
Ningbo 6
Orange 6
Saint Petersburg 6
Toronto 6
Jiaxing 5
Mountain View 5
Rome 5
Augusta 4
Bologna 4
Florence 4
Monmouth Junction 4
Shenzhen 4
Alghero 3
Borås 3
Brno 3
Chengdu 3
Fuzhou 3
Hangzhou 3
Hong Kong 3
New Bedfont 3
San Francisco 3
Taizhou 3
Vienna 3
Zhengzhou 3
Amsterdam 2
Ardabil 2
Belo Horizonte 2
Kilburn 2
Las Vegas 2
Lille 2
Malogoszcz 2
Millbury 2
Montijo 2
Mumbai 2
Nagold 2
Panicale 2
Poznan 2
Sarroch 2
Torino 2
Wenzhou 2
Wroclaw 2
Wuhan 2
Wuxi 2
Xi'an 2
Xian 2
Zola Predosa 2
Bangkok 1
Boydton 1
Bracke 1
Totale 58.751
Nome #
Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex 3.373
The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating 3.149
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 2.914
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex 2.724
Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation 2.664
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.506
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.335
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex 1.984
null 1.934
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.838
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus 1.728
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.589
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor 1.578
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.518
The cerebellar GABAA alpha6 subunit is differentially modulated by chronic ethanol exposure in normal (R100R) and mutated (Q100Q) sNP rats 1.496
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.470
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.390
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex 1.382
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechanisms in nucleus accumbens and prefrontal cortex 1.359
EFFECT OF NORADRENERGIC DENERVATION ON CEREBRAL CORTEX CATECHOLAMINES IN THE RAT 1.220
Effects of post-weaning social isolation on 5-alpha reductase: Relevance to dopaminergic pathway 1.212
Altered expression level of nucleus accumbens proteins in isolation-reared rats 1.194
Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications 1.112
null 1.078
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract 893
In vitro evidence for the presence of [3H]-haloperidol uptake in rat brain 860
Effect of the amisulpride isomers on rat catalepsy 741
Prenatal low-level exposure to CO alters postnatal development of hippocampal nitric oxide synthase and haem-oxygenase activities in rats 739
The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex 633
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect 626
Disulfiram and diethylditiocarbamate intoxication affects the storage and release of striatal dopamine 611
Effect of the amisulpride isomers on rat prolactinemia 607
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing 582
Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants 556
Chronic SCH 23390 produces tolerance to morphine extrapiramidal effects 546
Prenatal exposure to a low concentration of carbon monoxide disrupts hippocampal long-term potentiation in rat offspring 532
Dithiocarbamate pesticides affect glutamate transport in brain synaptic vesicles 509
Decreased adenosine A2 receptor function in morphine dependent rats 488
null 484
Effect of calcium antagonists on [3H] dopamine uptake 469
Chronic imipramine reduces [3H]SCH 23390 binding and DA sensitive adenylate cyclase in the limbic system 462
Differnatial interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of 3H-tyramine in dopaminergic and non-dopmeinergic brain regions 459
null 457
Differential mechanisms in the effects of disulfiram and diethyldithiocarbamate intoxication on striatal release and vesicular transport of glutamate 453
Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390 452
null 441
null 423
null 420
null 398
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats 378
The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex 350
Gating deficits in isolation-reared rats are correlated with alterations in protein expression in nucleus accumbens 308
Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals 191
Selected pyrethroid insecticides stimulate glutamate uptake in brain synaptic vesicles 88
New benzamide-derived 5-HT3 receptor antagonists which prevent the effects of ethanol on extracellular dopamine, and fail to reduce voluntary alcohol intake in rats 57
Lanthanides stimulate [3H]tyramine binding in the rat striatum 49
The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins 47
Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine 44
The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride 6
Totale 60.106
Categoria #
all - tutte 74.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013.760 0 0 0 0 5.970 4.167 2.082 436 223 231 271 380
2020/202117.903 469 654 564 5.870 3.924 1.824 1.265 1.058 274 713 770 518
2021/20223.089 348 178 228 227 226 239 204 165 241 286 353 394
2022/20234.135 311 443 419 340 344 421 223 485 301 287 351 210
2023/20244.358 226 186 182 251 395 609 619 317 235 334 457 547
2024/20253.119 561 750 791 617 400 0 0 0 0 0 0 0
Totale 60.106